Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: endocannabinoid palmitoylethanolamide (PEA)
Total 0 results
Nothing found
Sponsors and Collaborators
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Hospital Durand, Argentina
Alma Lasers Inc.
RMIT University, Melbourne, Australia
Mª Victoria Maestre Sanchez
Agency for Science, Technology and Research
ASST Cremona, Cremona
Everett Meyer
iCAD
Eurofins Genoma
Kupfer, David J., M.D.
Korean Society of Spine Surgery
Hospital ASEPEYO Sant Cugat
Neurophth Therapeutics Inc
GFI
Apollo Neuroscience, Inc.
Nacuity Pharmaceuticals, Inc.
Aptis Medical
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
View Full List
Medical Conditions
Chronic Constipation Symptoms
Recurrent Clear Cell Sarcoma of Soft Tissue
Scleredema
Corneal Cross-Linking
Major Liver Surgery
Splenic Trauma
RISS Stage III Plasma Cell Myeloma
Immune-Mediated Inflammatory Disease
Disorder of Fluid Balance
Luteal Phase Support
T-LGL Leukemia
The Strength Properties of the Aorta in Vitro
Metachronous Adenoma
Rheumatoid Arthritis(RA)
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Gastric Cancer Stage IIIB-IIIC
Treatment Decisions
Dienogest
Fever
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
View Full List
Drug Interventions
PD-1/PD-L1 inhibitor
Olopatadine
Capecitabine/cisplatin
GLPG1837 multiple ascending doses
Letrozole
Standard of care (SOC) for COVID-19
Camptosar
MLN2480
Intravenous Formulation of PD-0332991
Capecitabine and IMRT (if randomized to this arm)
RDX227675
Midazolam
Fospropofol disodium, propofol
THC
Oxycodone/acetaminophen 5/325 mg
Desvenlafaxine
Intravenous deferiprone
OnabotulinumtoxinA
Anticholinergic
TPN-101
View Full List
CROs by country
Contract Research Organizations in Azerbaijan
Contract Research Organizations in Bahrain
Contract Research Organizations in Chile
Contract Research Organizations in Israel
Contract Research Organizations in Kenya
Contract Research Organizations in Mexico
Contract Research Organizations in Moldova
Contract Research Organizations in Romania
Contract Research Organizations in Russia
Contract Research Organizations in Serbia
Contract Research Organizations in Slovakia
Contract Research Organizations in Thailand
Contract Research Organizations in Turkmenistan
CRO list by country
CROs in Kazakhstan
ACROSS Global
Dokumeds
GCT (Global Clinical Trials)
SGS
MB Quest
IQVIA
All CROs in Kazakhstan
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe